Ultrasmall superparamagnetic iron oxide nanoparticles coated with fucoidan for molecular MRI of intraluminal thrombus.
暂无分享,去创建一个
Jean-Baptiste Michel | Michimasa Suzuki | Murielle Maire | Frédéric Chaubet | Didier Letourneur | Jean-Michel Serfaty | J. Serfaty | C. Ménager | J. Michel | F. Chaubet | D. Letourneur | L. Louedec | F. Rouzet | Michimasa Suzuki | G. Autret | Liliane Louedec | Anne Beilvert | C. Choqueux | C. Chauvierre | Oualid Haddad | Gwennhael Autret | Laure Bachelet-Violette | François Rouzet | Christine Menager | Christine Choqueux | Pierre Saboural | Cédric Chauvierre | O. Haddad | Laure Bachelet-Violette | M. Maire | Pierre Saboural | A. Beilvert | Murielle Maire
[1] G. Frija,et al. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. , 1993, Magnetic resonance imaging.
[2] Henrik S. Thomsen,et al. Recent hot topics in contrast media , 2011, European Radiology.
[3] Jean-Baptiste Michel,et al. Thrombus versus Wall Biological Activities in Experimental Aortic Aneurysms , 2009, Journal of Vascular Research.
[4] Jean-Baptiste Michel,et al. Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans , 2010, Cardiovascular research.
[5] A. Kondo,et al. Improved method for fluorescence labeling of sugar chains with sialic acid residues. , 1990, Agricultural and biological chemistry.
[6] Z. Fayad,et al. Magnetic Resonance Molecular Imaging of Thrombosis in an Arachidonic Acid Mouse Model Using an Activated Platelet Targeted Probe , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[7] D. Buxton,et al. Clinical Implications of Molecular Imaging Research Molecular Imaging of Aortic Aneurysms Animal Studies , 2022 .
[8] V. Fuster,et al. In vivo characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular magnetic resonance imaging. , 2011, Journal of the American College of Cardiology.
[9] P. Merlet,et al. 99 mTc-Annexin-V Functional Imaging of Luminal Thrombus Activity in Abdominal Aortic Aneurysms , 2006 .
[10] Fabien Hyafil,et al. Ferumoxtran-10–Enhanced MRI of the Hypercholesterolemic Rabbit Aorta: Relationship Between Signal Loss and Macrophage Infiltration , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[11] Hisao Ikeda,et al. Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates. , 2002, Journal of the American College of Cardiology.
[12] J. Deux,et al. Low Molecular Weight Fucoidan Prevents Neointimal Hyperplasia in Rabbit Iliac Artery In-Stent Restenosis Model , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[13] Calum Gray,et al. Abdominal Aortic Aneurysm Growth Predicted by Uptake of Ultrasmall Superparamagnetic Particles of Iron Oxide: A Pilot Study , 2011, Circulation. Cardiovascular imaging.
[14] I. Bakunina,et al. Structure, biological activity, and enzymatic transformation of fucoidans from the brown seaweeds , 2008, Biotechnology journal.
[15] Martin J Graves,et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. , 2009, Journal of the American College of Cardiology.
[16] 横山 晋二,et al. Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates , 2005 .
[17] René M. Botnar,et al. In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent , 2004, Circulation.
[18] Y. Castier,et al. Porphyromonas gingivalis Participates in Pathogenesis of Human Abdominal Aortic Aneurysm by Neutrophil Activation. Proof of Concept in Rats , 2011, PloS one.
[19] Toxicological evaluation of fucoidan from Undaria pinnatifidain vitro and in vivo , 2010, Phytotherapy research : PTR.
[20] Y. Huo,et al. P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall. , 2009, Trends in cardiovascular medicine.
[21] Bo Li,et al. Fucoidan: Structure and Bioactivity , 2008, Molecules.
[22] M. Biran,et al. MRI of inducible P‐selectin expression in human activated platelets involved in the early stages of atherosclerosis , 2011, NMR in biomedicine.
[23] Jean-Baptiste Michel,et al. Intraplaque haemorrhages as the trigger of plaque vulnerability , 2011, European heart journal.
[24] D Revel,et al. Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI. , 1993, Magnetic resonance imaging.
[25] Brian K Rutt,et al. Imaging single mammalian cells with a 1.5 T clinical MRI scanner , 2003, Magnetic resonance in medicine.
[26] Jean-Baptiste Michel,et al. MR imaging of iron phagocytosis in intraluminal thrombi of abdominal aortic aneurysms in humans. , 2010, Radiology.
[27] Zahi A Fayad,et al. Chronic Thrombus Detection With In Vivo Magnetic Resonance Imaging and a Fibrin-Targeted Contrast Agent , 2005, Circulation.
[28] P. Merlet,et al. 99mTc-Annexin-V Functional Imaging of Luminal Thrombus Activity in Abdominal Aortic Aneurysms , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[29] René M. Botnar,et al. Molecular Magnetic Resonance Imaging of Atrial Clots in a Swine Model , 2005, Circulation.
[30] G. Pasterkamp,et al. Targeting adhesion molecules in cardiovascular disorders. , 2008, Cardiovascular & hematological disorders drug targets.
[31] F. Chaubet,et al. Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets. , 2009, Biochimica et biophysica acta.
[32] Jean-Baptiste Michel,et al. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. , 2006, The American journal of pathology.
[33] B. Furie,et al. Role of P-selectin and PSGL-1 in coagulation and thrombosis , 2004, Thrombosis and Haemostasis.
[34] C. Glüer,et al. Biological Properties of Iron Oxide Nanoparticles for Cellular and Molecular Magnetic Resonance Imaging , 2010, International journal of molecular sciences.
[35] J. Freedman,et al. Platelets and innate immunity , 2010, Cellular and Molecular Life Sciences.
[36] C. Goergen,et al. Molecular Imaging of Experimental Abdominal Aortic Aneurysms , 2013, TheScientificWorldJournal.
[37] J. Michel,et al. Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. , 2004, The American journal of pathology.
[38] Chun Yuan,et al. Presence of Intraplaque Hemorrhage Stimulates Progression of Carotid Atherosclerotic Plaques: A High-Resolution Magnetic Resonance Imaging Study , 2005, Circulation.
[39] J. Debatin,et al. Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.
[40] Philippe Robert,et al. Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.
[41] S A Wickline,et al. Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.
[42] A. Varki,et al. Selectin ligands. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[43] S. Neubauer,et al. Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[44] J. Alsac,et al. Radiolabeled Fucoidan as a P-Selectin Targeting Agent for In Vivo Imaging of Platelet-Rich Thrombus and Endothelial Activation , 2011, The Journal of Nuclear Medicine.
[45] J. Deux,et al. Iron oxide nanoparticle-labeled rat smooth muscle cells: cardiac MR imaging for cell graft monitoring and quantitation. , 2005, Radiology.
[46] J. Michel,et al. Elastase-induced experimental aneurysms in rats. , 1990, Circulation.
[47] J. Michel,et al. Low-Molecular-Weight Fucoidan Promotes Therapeutic Revascularization in a Rat Model of Critical Hindlimb Ischemia , 2003, Journal of Pharmacology and Experimental Therapeutics.